← FDA Drug Approvals (Drugs@FDA)

UBRELVY

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2019-12-23

Drug application

FDA Application #

NDA211765

Application type

New Drug Application

Brand name

UBRELVY

Generic name

UBROGEPANT

Active ingredients

UBROGEPANT

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

Allergan, Inc.

First approval

2019-12-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown